Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Amedisys, Inc. (AMED) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Amedisys, Inc. (AMED) - free report >>
Image: Bigstock
New Strong Sell Stocks for March 4th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Amedisys (AMED - Free Report) : is a provides of home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The Zacks Consensus Estimate for its current year earnings has been revised 9% downward over the last 60 days.
Credit Acceptance (CACC - Free Report) : focuses on offering financing programs, and related products and services to automobile dealers in the United States enabling them to sell vehicles to consumers irrespective of their credit history. The Zacks Consensus Estimate for its current year earnings has been revised 7.1% downward over the last 60 days.
Exponent (EXPO - Free Report) : this company is an engineering and scientific consulting firm providing solutions to complex problems in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. The Zacks Consensus Estimate for its current year earnings has been revised almost 7.2% downward over the last 60 days.
View the entire Zacks Rank #5 List.